Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Common Equity (2022 - 2025)

Core Laboratories (CLB) has 4 years of Common Equity data on record, last reported at $271.3 million in Q3 2025.

  • For Q3 2025, Common Equity rose 5.82% year-over-year to $271.3 million; the TTM value through Sep 2025 reached $271.3 million, up 5.82%, while the annual FY2024 figure was $252.0 million, 9.65% up from the prior year.
  • Common Equity reached $271.3 million in Q3 2025 per CLB's latest filing, up from $267.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $271.3 million in Q3 2025 and bottomed at $173.8 million in Q2 2022.
  • Average Common Equity over 4 years is $229.6 million, with a median of $233.6 million recorded in 2023.
  • Peak YoY movement for Common Equity: grew 26.38% in 2023, then grew 5.82% in 2025.
  • A 4-year view of Common Equity shows it stood at $189.0 million in 2022, then increased by 21.62% to $229.8 million in 2023, then increased by 9.65% to $252.0 million in 2024, then grew by 7.68% to $271.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $271.3 million in Q3 2025, $267.3 million in Q2 2025, and $259.4 million in Q1 2025.